TeraRecon's New Intuition ProductLine Delivers Al Productivity andIndustry-leading Cardiac MRWorkflows, All Delivered Through aRobust Software-as-a-Service (SaaS)Platform
by TeraRecon, on Oct 23, 2024 1:59:07 PM
Enhanced clinical benefits of Intuition for cardiac CT and MR workflows are nowavailable for use across the imaging enterprise, and delivered via the latest.scalable cloud technologies
CAMBRIDGE, Mass, Oct. 23, 2024/BUSINESS WIRE -- ConcertAl's TeraRecon, theleader in medical imaging advanced visualization, clinical Al, and workflowautomation, today announced updates to its Intuition platform with new best-in
class cardiac magnetic resonance (MR) medical imaging capabilities. These clinicalinnovations are now available across all deployment models and on the latest cloudinfrastructure.
Intuition's extensive cardiac modules optimize workflows and augment diagnosticcapabilities to cover common cardiac MR cases. Intuition integrates a range ofcardiac assessment tools to streamline and semi-automate workflows
whilemaintaining a consistent user experience.This Intuition 4.10 release represents morethan 200 feature enhancements requested most by the largest user-case in cardiacimaging, including a dedicated cardiac MR viewer with optimized
hanging protocolsand specific tooling to seamlessly measure and report on cardiac MR cases.Contouring, Tl/T2/T2*mapping, 2D flow, strain analysis, and perfusion quantificationprovide deep insights into cardiac function to
assure confident diagnoses andinforming treatment plans.
"TeraRecon's Intuition 4.10 release includes significant new enhancements to cardiacMR workflows," said Dr. Christopher Maroules MD, CoO of Innovation Health Services."l have been using TeraRecon's Cardiac CT capabilities for decades.
This releaseallows me to start standardizing my post-processing cardiac workflows onto a singlebroad tool for imaging workflows. The versatility of the dedicated cardiac MR viewerand various cardiac MR workflows enable me to conduct
my day-to-day cardiac MRanalysis in a streamlined and consistent manner.
"We are especially excited about the new Intuition cloud-based SaaS offering,” saidJeff Elton Ph.D., CEO of ConcertAl. “This deployment provides a wide range ofbenefits, including adaptive compute and storage that are always on to
scale up anddown as required; seamless and effortless clinical software updates for access to thelatest features; ultimate scalability; and in-depth monitoring and analyticssupporting different operational workflows and cross-system
clinical models." Ascardiac MR becomes more prevalent in imaging,the new Intuition features anexpanded range of cardiac MR specific quantification tools that can help enhancediagnostic precision, such as
ECV (Tl) mapping, short- and long-axis segmentation,EF calculations, 2D flow analysis, a new global strain analysis workflow, qualitativeand semi-quantitative perfusion assessment, and enhanced cardiac MR reporting.
"This new release of Intuition brings together a significant set ofenhancements toour category-leading advanced visualization imaging software," said Sinan BatmanPh.D., Chief Technology Officer of TeraRecon.“it enhances our cardiac
MRcapabilities and further expands the benefits of our multi-modality advancedvisualization software for the assessment of cardiac function. We have always beenthe preferred solution for cardiac imaging workflows, and intuition 4.10
reflects ourongoing investment in, and prioritization of, this critical community of radiologistsand cardiac imagers. With cloud-enabled SaaS capabilities, Intuition enables us tomeet clinicians where they are, giving them the choice to
deploy Intuition accordingto their preferred configuration, maximizing their ability to be productive, manageand diagnose disease anytime, anywhere." In addition, Intuition elevates clinicaldecision making by seamlessly integrating
advanced Al-powered workflows directlywithin the Intuition viewer. Through partnerships with leading third-party Alvendors, Intuition enhances diagnostic precision and planning capabilities acrossmultiple specialties. In oncology, it
empowers clinicians with Al-driven lung nodulescreening and detection, significantly improving early detection. In cardiology,Intuition's Al-based processing accelerates coronary disease assessment bydelivering precise Ca scoring
computations. In radiology, Intuition's Al-basedprocessing automates the detection of bone fractures, breast density measurement.MR brain perfusion, and more.
For more information about TeraRecon offerings, visit terarecon.com
About TeraRecon: With solutions deployed in over 1,900 clinical sites globally, theTeraRecon products of ConcertAl are an award-winning suite of solutions for Al-empowered radiology, oncology, cardiology, neurology, and vascular
surgery.TeraRecon solutions use an Al-first approach to allow a single, unified, and simplifiedclinical workflow that can improve efficiencies and deliver actionable, physician.guided insights. For more information, visit us at www.terarecon.com.
About ConcertAl: ConcertAl is the leader in predictive and generative Al Saas andReal-World Data research solutions for healthcare and life sciences. Our mission is toaccelerate insights and outcomes for patients through research-ready data, Altechnologies, and scientific expertise in partnership with the leading biomedicalinnovators, health care providers, and medical societies. ConcertAl solutions aredeployed at 2,000 clinical providers around the world and 45 leadingbiopharmaceutical companies. Headquartered in Cambridge, MA, ConcertAl hasoffices in Frankfurt, London, Philadelphia, Raleigh-Durham, Bangalore, and Tokyo.For more information, visit us at www.concertai.com